FamGenix

FamGenix is a digital health company that provides a comprehensive platform for capturing and managing family health history to assess genetic risk. The company's software enables patients to share their medical history through a mobile app, which then generates pedigrees and identifies individuals who meet clinical criteria for genetic testing. Integrated into clinical workflows, FamGenix helps healthcare providers streamline risk assessment for hereditary conditions such as cancer and cardiovascular disease. The platform is designed to improve the efficiency of genetic counseling and clinical genetics departments by automating data collection and pedigree drawing. The company was acquired by Agilent Technologies in 2022 to enhance their clinical genomics portfolio.